Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Truus Abbink

Truus Abbink

Person: Academic

20122019
No photo of Moji Aghajani

Moji Aghajani

Person: Academic

20122019
Photo of Sandra Amor

Sandra Amor

Person: Academic

19832019

Research Output 1983 2020

Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial

Schmitz, C., Hüttmann, A., Müller, S. P., Hanoun, M., Boellaard, R., Brinkmann, M., Jöckel, K-H., Dührsen, U. & Rekowski, J., 1 Jan 2020, In : European Journal of Cancer. 124, p. 25-36 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

microRNA-132 is overexpressed in glia in temporal lobe epilepsy and reduces the expression of pro-epileptogenic factors in human cultured astrocytes

Korotkov, A., Broekaart, D. W. M., Banchaewa, L., Pustjens, B., van Scheppingen, J., Anink, J. J., Baayen, J. C., Idema, S., Gorter, J. A., van Vliet, E. A. & Aronica, E., 1 Jan 2020, In : GLIA. 68

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Patients’ expectations of autologous hematopoietic stem cell transplantation as a treatment for MS

de Kleermaeker, F. G. C. M., Uitdehaag, B. M. J. & van Oosten, B. W., 2020, In : Multiple Sclerosis and Related Disorders. 37, 101467.

Research output: Contribution to journalArticleAcademicpeer-review

Activities 1990 2020

Functional imaging

Menno Schoonheim (Speaker)
23 Jun 2020

Activity: Talk or presentationInvited talk

Cognitive impairment and the network collapse in multiple sclerosis

Menno Schoonheim (Speaker)
16 Jan 2020

Activity: Talk or presentationInvited talk

Multiple sclerosis: New avenues to functional connectivity analyses

Menno Schoonheim (Speaker)
25 Oct 2019

Activity: Talk or presentationInvited talk

Press / Media

Regulation of lifespan by neural excitation and REST

Linda Douw

21/10/2019

1 media contribution

Press/Media: Expert Comment

Natalizumab

Menno Schoonheim

01/07/2019

1 media contribution

Press/Media: Interview